The mouse light/dark box test

被引:971
作者
Bourin, M [1 ]
Hascoët, M [1 ]
机构
[1] Fac Med, EA 3256, F-44035 Nantes 1, France
关键词
antidepressant; antipsychotic; anxiolytic; light/dark test; mouse; neuropeptide receptor ligand;
D O I
10.1016/S0014-2999(03)01274-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The light/dark test is based on the innate aversion of rodents to brightly illuminated areas and on the spontaneous exploratory behaviour of rodents in response to mild stressors, that is, novel environment and light. The test apparatus consists of a small dark safe compartment (one third) and a large illuminated aversive compartment (two thirds). The test was developed with male mice. The strain, weight and age may be crucial factors. The extent to which an anxiolytic compound can facilitate exploratory activity depends on the baseline level in the control group. Differences between the type and severity of external stressors might account for the variable results reported by different laboratories. The light/dark test may be useful to predict anxiolytic-like or anxiogenic-like activity in mice. Transitions have been reported to be an index of activity-exploration because of habituation over time, and the time spent in each compartment to be a reflection of aversion. Classic anxiolytics (benzodiazepines) as well as the newer anxiolytic-like compounds (e.g. serotonergic drugs or drugs acting on neuropeptide receptors) can be detected using this paradigm. It has the advantages of being quick and easy to use, without requiring the prior training of animals. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:55 / 65
页数:11
相关论文
共 106 条
  • [21] ACTIONS OF 5-HYDROXYTRYPTOPHAN TO INHIBIT AND DISINHIBIT MOUSE BEHAVIOR IN THE LIGHT/DARK TEST
    CHENG, CHK
    COSTALL, B
    KELLY, ME
    NAYLOR, RJ
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 255 (1-3) : 39 - 49
  • [22] EXPLORATION OF MICE IN A BLACK AND WHITE TEST BOX - VALIDATION AS A MODEL OF ANXIETY
    COSTALL, B
    JONES, BJ
    KELLY, ME
    NAYLOR, RJ
    TOMKINS, DM
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1989, 32 (03) : 777 - 785
  • [23] ANXIOLYTIC EFFECTS OF CCK-B ANTAGONISTS
    COSTALL, B
    DOMENEY, AM
    HUGHES, J
    KELLY, ME
    NAYLOR, RJ
    WOODRUFF, GN
    [J]. NEUROPEPTIDES, 1991, 19 : 65 - 73
  • [24] BEHAVIORAL INTERACTIONS BETWEEN 5-HYDROXYTRYPTOPHAN, NEUROLEPTIC AGENTS AND 5-HT RECEPTOR ANTAGONISTS IN MODIFYING RODENT RESPONDING TO AVERSIVE SITUATIONS
    COSTALL, B
    NAYLOR, RJ
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (07) : 2989 - 2999
  • [25] ANXIOLYTIC POTENTIAL OF 5-HT3 RECEPTOR ANTAGONISTS
    COSTALL, B
    NAYLOR, RJ
    [J]. PHARMACOLOGY & TOXICOLOGY, 1992, 70 (03): : 157 - 162
  • [26] ACTIONS OF BUSPIRONE IN A PUTATIVE MODEL OF ANXIETY IN THE MOUSE
    COSTALL, B
    KELLY, ME
    NAYLOR, RJ
    ONAIVI, ES
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1988, 40 (07) : 494 - 500
  • [27] The influence of 5-HT2 and 5-HT4 receptor antagonists to modify drug induced disinhibitory effects in the mouse light/dark test
    Costall, B
    Naylor, RJ
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1997, 122 (06) : 1105 - 1118
  • [28] SITES OF ACTION OF ONDANSETRON TO INHIBIT WITHDRAWAL FROM DRUGS OF ABUSE
    COSTALL, B
    JONES, BJ
    KELLY, ME
    NAYLOR, RJ
    ONAIVI, ES
    TYERS, MB
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 36 (01) : 97 - 104
  • [29] TOWARD A DEVELOPMENTAL EPIDEMIOLOGY OF THE DISRUPTIVE BEHAVIOR DISORDERS
    COSTELLO, EJ
    ANGOLD, A
    [J]. DEVELOPMENT AND PSYCHOPATHOLOGY, 1993, 5 (1-2) : 91 - 101
  • [30] PRELIMINARY-REPORT OF A SIMPLE ANIMAL BEHAVIOR MODEL FOR THE ANXIOLYTIC EFFECTS OF BENZODIAZEPINES
    CRAWLEY, J
    GOODWIN, FK
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1980, 13 (02) : 167 - 170